Photo from Stephen Liu/X
Apr 28, 2024, 10:18
Stephen Liu: Interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter:
“Certainly confounders here, but interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer. In this group, 58% of deferred patients eventually had systemic therapy. OS longer in deferred group (20.6m vs 11.5m).”
Visit the article website.
Source: Stephen Liu/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31
Dec 22, 2024, 05:05